New Potomac Partners, LLC Amgen Inc Transaction History

New Potomac Partners, LLC

$192 Million
Q3 2024

A detailed history of New Potomac Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, New Potomac Partners, LLC holds 100 shares of AMGN stock, worth $26,264. This represents 0.02% of its overall portfolio holdings.

Number of Shares

100

Holding current value

$26,264

% of portfolio

0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$309.38 - $337.38 $30,938 - $33,738	100 New	100 $32,000
Q4 2020 Jan 28, 2021	SELL	$216.38 - $257.67 $104,944 - $124,969	-485 Closed	0 $0
Q3 2020 Oct 23, 2020	SELL	$234.65 - $260.95 $14,079 - $15,657	-60 Reduced 11.01%	485 $123,000
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $5,934 - $7,282	-30 Reduced 5.22%	545 $129,000
Q1 2020 Apr 24, 2020	SELL	$182.24 - $241.7 $800,033 - $1.06 Million	-4,390 Reduced 88.42%	575 $117,000
Q4 2019 Jan 23, 2020	SELL	$189.21 - $243.2 $68,115 - $87,552	-360 Reduced 6.76%	4,965 $1.2 Million
Q3 2019 Oct 21, 2019	SELL	$174.11 - $208.62 $24,375 - $29,206	-140 Reduced 2.56%	5,325 $1.03 Million
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $53,344 - $62,531	-320 Reduced 5.53%	5,465 $1.01 Million
Q1 2019 Apr 23, 2019	SELL	$180.87 - $203.88 $51,547 - $58,105	-285 Reduced 4.7%	5,785 $1.1 Million
Q4 2018 Jan 23, 2019	BUY	$178.4 - $208.25 $10,704 - $12,495	60 Added 1.0%	6,070 $1.18 Million
Q3 2018 Oct 23, 2018	BUY	$185.29 - $208.89 $13,711 - $15,457	74 Added 1.25%	6,010 $1.25 Million
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $2,490 - $2,797	-15 Reduced 0.25%	5,936 $1.1 Million
Q1 2018 Apr 18, 2018	BUY	$169.43 - $198.0 $11,012 - $12,870	65 Added 1.1%	5,951 $1.02 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $993,497 - $1.11 Million	5,886	5,886 $1.02 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Potomac Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Potomac Partners, LLC with notifications on news.

Account

New Potomac Partners, LLC Amgen Inc Transaction History